Morning Overview on MSN
Researchers identify a promising new drug target for tuberculosis
A team of scientists has identified an enzyme called PurF as a new drug target for tuberculosis, offering a fresh line of ...
Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.
InvestorsHub on MSN
Akari Therapeutics to present ADC research at AACR Annual Meeting 2026
Akari Therapeutics Plc (NASDAQ:AKTX) said its research has been selected for presentation at the American Association for ...
New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21Preclinical data highlight combination potential for ZW191, a folate receptor alpha (FR⍺)-targeting ant ...
A rock measuring 900 meters is on a journey through our solar system, providing what is arguably one of the strongest pieces ...
A sample collected by the Hayabusa 2 spacecraft from the spinning top-like asteroid contained the nucleobases adenine, guanine, cytosine, thymine, and uracil.
When a virus infects a bacterial cell, the viral genome is the first component to be fully injected into the cell, making it an ideal immune target. A bacterial enzyme anchored to the membrane ...
Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest ...
A team led by La Trobe University has drawn inspiration from nature to develop a breakthrough sensor that can rapidly track ...
The database of 200 million protein-structure predictions now includes homodimers, adding new biological relevance.
Published in the journal Proceedings of the National Academy of Sciences, the study is the first to identify a sugar metabolism driving immune suppression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results